Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy

Supavit Chesdachai1, Natalia E Castillo Almeida1, Isin Y Comba1

  • 1Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Idcases
|April 23, 2021
PubMed

Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed acute invasive fungal rhinosinusitis (AIFR) from Fusarium species after CAR-T therapy. Our photos illustrated the classic clinical, endoscopic, and histopathologic findings of AIFR.

Related Concept Videos